|
1.
|
Du P, Camacho F, Zurlo J, Lengerich EJ. Human immunodeficiency virus testing behaviors among US adults: the roles of individual factors, legislative status, and public health resources. Sex Transm Dis. 2011 Sep; 38(9):858-64.
|
|
|
|
|
2.
|
Du P, Lemkin A, Kluhsman B, Chen J, Roth RE, MacEachren A, Meyers C, Zurlo JJ, Lengerich EJ. The roles of social domains, behavioral risk, health care resources, and chlamydia in spatial clusters of US cervical cancer mortality: not all the clusters are the same. Cancer Causes Control. 2010 Oct; 21(10):1669-83.
|
|
|
|
|
3.
|
Koszyk-Szewczyk A, Bayerl M, Zurlo J, Drabick JJ. Epstein Barré virus-negative diffuse large B-cell lymphoma in an HIV-infected man with a durable complete remission on highly active antiretroviral therapy alone. South Med J. 2010 Jan; 103(1):76-80.
|
|
|
|
|
4.
|
Masters PA, O'Bryan TA, Zurlo J, Miller DQ, Joshi N. Trimethoprim-sulfamethoxazole revisited. Arch Intern Med. 2003 Feb 24; 163(4):402-10.
|
|
|
|
|
5.
|
Slusser SO, Boehmer JP, Zurlo J, Ruggiero F, Ouyang A. Questioning the clinical significance of upper gastrointestinal cytomegalovirus disease following heart transplantation. Dig Dis Sci. 1995 Aug; 40(8):1824-30.
|
|
|
|
|
6.
|
Zurlo JJ, Wood L, Gaglione MM, Polis MA. Effect of splenectomy on T lymphocyte subsets in patients infected with the human immunodeficiency virus. Clin Infect Dis. 1995 Apr; 20(4):768-71.
|
|
|
|
|
7.
|
Zurlo JJ, O'Neill D, Polis MA, Manischewitz J, Yarchoan R, Baseler M, Lane HC, Masur H. Lack of clinical utility of cytomegalovirus blood and urine cultures in patients with HIV infection. Ann Intern Med. 1993 Jan 1; 118(1):12-7.
|
|
|
|
|
8.
|
Palestine AG, Polis MA, De Smet MD, Baird BF, Falloon J, Kovacs JA, Davey RT, Zurlo JJ, Zunich KM, Davis M, et al. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann Intern Med. 1991 Nov 1; 115(9):665-73.
|
|
|
|
|
9.
|
Davey RT, Davey VJ, Metcalf JA, Zurlo JJ, Kovacs JA, Falloon J, Polis MA, Zunich KM, Masur H, Lane HC. A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infection. J Infect Dis. 1991 Jul; 164(1):43-52.
|
|
|
|